Effect of Evogliptin on Bone Metabolism in Human

Sponsor
DongGuk University
Study ID
NCT02587975
Phase
PHASE4
Status
Unknown

Conditions

Eligibility Criteria

Sex
FEMALE
Age
N/A - N/A
Healthy Volunteers
Accepted

Interventions

Study Details

This study is designed to measure the effect of evogliptin on bone metabolism in healthy volunteers.

Key Dates

First listed
Oct 27, 2015
Start date
Jun 30, 2016
Status verified
Jul 2016
Primary completion
Nov 30, 2016
Completion
Mar 31, 2017

Study Design

Enrollment
20 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Evogliptin 10 mg
    Single oral administration of 2 tablets of evogliptin 5 mg with water 250 mL

Primary Outcome Measure

Serum concentration of C-terminal telopeptide after treatment in comparison with the baseline [ Time Frame: Predose and 1, 2, 3, 4, 6, 14, 20, 24 h postdose on Day 1 and Day 2 ]

Central Contacts

Related Studies